Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements Limited has announced that the National Company Law Tribunal (NCLT), Ahmedabad Bench, scheduled a hearing for January 22, 2026 regarding the Scheme of Arrangement between Sanghi Industries Limited (transferor) and Ambuja Cements (transferee). The notice was published in Indian Express and Financial Express on December 2, 2025. This scheme requires shareholder approval and NCLT confirmation before implementation. Shareholders should monitor tribunal proceedings for potential merger implications.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 2 December 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 2 December 2025

CANBK Canara Bank Corporate Action ICICIPRULI ICICI Prudential Life Insurance Company Limited Corporate Action SIEMENS Siemens Limited Announcement AXISBANK Axis Bank Limited Corporate Action CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action MUTHOOTFIN Muthoot Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.